Z

Zevra Therapeutics Inc
NASDAQ:ZVRA

Watchlist Manager
Zevra Therapeutics Inc
NASDAQ:ZVRA
Watchlist
Price: 9.03 USD 4.27% Market Closed
Market Cap: 475.2m USD
Have any thoughts about
Zevra Therapeutics Inc?
Write Note

Zevra Therapeutics Inc
Free Cash Flow

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Zevra Therapeutics Inc
Free Cash Flow Peer Comparison

Comparables:
JNJ
BMY
PFE
MRK
LLY

Competitive Free Cash Flow Analysis
Latest Figures & CAGR of Competitors

Company Free Cash Flow CAGR 3Y CAGR 5Y CAGR 10Y
Z
Zevra Therapeutics Inc
NASDAQ:ZVRA
Free Cash Flow
-$56.3m
CAGR 3-Years
N/A
CAGR 5-Years
-3%
CAGR 10-Years
N/A
Johnson & Johnson
NYSE:JNJ
Free Cash Flow
$20.7B
CAGR 3-Years
-3%
CAGR 5-Years
1%
CAGR 10-Years
4%
Bristol-Myers Squibb Co
NYSE:BMY
Free Cash Flow
$13.8B
CAGR 3-Years
-2%
CAGR 5-Years
13%
CAGR 10-Years
15%
Pfizer Inc
NYSE:PFE
Free Cash Flow
$4.8B
CAGR 3-Years
-45%
CAGR 5-Years
-15%
CAGR 10-Years
-11%
Merck & Co Inc
NYSE:MRK
Free Cash Flow
$14.8B
CAGR 3-Years
21%
CAGR 5-Years
11%
CAGR 10-Years
3%
Eli Lilly and Co
NYSE:LLY
Free Cash Flow
-$2.3B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Zevra Therapeutics Inc's Free Cash Flow?
Free Cash Flow
-56.3m USD

Based on the financial report for Jun 30, 2024, Zevra Therapeutics Inc's Free Cash Flow amounts to -56.3m USD.

What is Zevra Therapeutics Inc's Free Cash Flow growth rate?
Free Cash Flow CAGR 5Y
-3%

Over the last year, the Free Cash Flow growth was -135%.

Back to Top